annual EBIT:
-$281.99M+$215.19M(+43.28%)Summary
- As of today (June 29, 2025), IBRX annual earnings before interest & taxes is -$281.99 million, with the most recent change of +$215.19 million (+43.28%) on December 31, 2024.
- During the last 3 years, IBRX annual EBIT has risen by +$53.00 million (+15.82%).
- IBRX annual EBIT is now -82.70% below its all-time high of -$154.34 million, reached on December 31, 2019.
Performance
IBRX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$101.03M-$56.76M(-128.20%)Summary
- As of today (June 29, 2025), IBRX quarterly earnings before interest & taxes is -$101.03 million, with the most recent change of -$56.76 million (-128.20%) on March 31, 2025.
- Over the past year, IBRX quarterly EBIT has increased by +$1.16 million (+1.13%).
- IBRX quarterly EBIT is now -184.45% below its all-time high of -$35.52 million, reached on March 31, 2020.
Performance
IBRX quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$286.38M+$1.16M(+0.40%)Summary
- As of today (June 29, 2025), IBRX TTM earnings before interest & taxes is -$286.38 million, with the most recent change of +$1.16 million (+0.40%) on March 31, 2025.
- Over the past year, IBRX TTM EBIT has increased by +$226.22 million (+44.13%).
- IBRX TTM EBIT is now -706.25% below its all-time high of -$35.52 million, reached on March 31, 2020.
Performance
IBRX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
IBRX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +43.3% | +1.1% | +44.1% |
| 3 y3 years | +15.8% | -6.9% | +18.7% |
| 5 y5 years | -82.7% | -184.4% | -706.3% |
IBRX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +43.3% | -128.2% | +58.6% | at high | +44.1% |
| 5 y | 5-year | -82.7% | +43.3% | -184.4% | +58.6% | -706.3% | +44.1% |
| alltime | all time | -82.7% | +43.3% | -184.4% | +58.6% | -706.3% | +44.1% |
IBRX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$101.03M(+128.2%) | -$286.38M(-0.4%) |
| Dec 2024 | -$281.99M(-43.3%) | -$44.27M(-2.7%) | -$287.54M(-41.0%) |
| Sep 2024 | - | -$45.51M(-52.4%) | -$487.07M(-3.0%) |
| Jun 2024 | - | -$95.56M(-6.5%) | -$502.19M(-2.0%) |
| Mar 2024 | - | -$102.19M(-58.1%) | -$512.60M(+3.1%) |
| Dec 2023 | -$497.18M(+34.3%) | -$243.81M(+302.2%) | -$497.18M(+42.3%) |
| Sep 2023 | - | -$60.62M(-42.8%) | -$349.47M(-8.8%) |
| Jun 2023 | - | -$105.98M(+22.1%) | -$383.24M(+5.8%) |
| Mar 2023 | - | -$86.77M(-9.7%) | -$362.40M(-2.1%) |
| Dec 2022 | -$370.14M | -$96.10M(+1.8%) | -$370.16M(+2.5%) |
| Sep 2022 | - | -$94.40M(+10.9%) | -$361.12M(+2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$85.14M(-9.9%) | -$351.54M(-0.2%) |
| Mar 2022 | - | -$94.53M(+8.6%) | -$352.21M(+5.1%) |
| Dec 2021 | -$334.99M(+54.4%) | -$87.06M(+2.6%) | -$334.99M(+6.7%) |
| Sep 2021 | - | -$84.81M(-1.2%) | -$313.87M(+6.5%) |
| Jun 2021 | - | -$85.81M(+11.0%) | -$294.70M(+13.9%) |
| Mar 2021 | - | -$77.31M(+17.2%) | -$258.75M(+19.3%) |
| Dec 2020 | -$216.96M(+40.6%) | -$65.95M(+0.5%) | -$216.96M(+43.7%) |
| Sep 2020 | - | -$65.64M(+31.7%) | -$151.01M(+76.9%) |
| Jun 2020 | - | -$49.85M(+40.3%) | -$85.37M(+140.3%) |
| Mar 2020 | - | -$35.52M | -$35.52M |
| Dec 2019 | -$154.34M | - | - |
FAQ
- What is ImmunityBio annual earnings before interest & taxes?
- What is the all time high annual EBIT for ImmunityBio?
- What is ImmunityBio annual EBIT year-on-year change?
- What is ImmunityBio quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for ImmunityBio?
- What is ImmunityBio quarterly EBIT year-on-year change?
- What is ImmunityBio TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for ImmunityBio?
- What is ImmunityBio TTM EBIT year-on-year change?
What is ImmunityBio annual earnings before interest & taxes?
The current annual EBIT of IBRX is -$281.99M
What is the all time high annual EBIT for ImmunityBio?
ImmunityBio all-time high annual earnings before interest & taxes is -$154.34M
What is ImmunityBio annual EBIT year-on-year change?
Over the past year, IBRX annual earnings before interest & taxes has changed by +$215.19M (+43.28%)
What is ImmunityBio quarterly earnings before interest & taxes?
The current quarterly EBIT of IBRX is -$101.03M
What is the all time high quarterly EBIT for ImmunityBio?
ImmunityBio all-time high quarterly earnings before interest & taxes is -$35.52M
What is ImmunityBio quarterly EBIT year-on-year change?
Over the past year, IBRX quarterly earnings before interest & taxes has changed by +$1.16M (+1.13%)
What is ImmunityBio TTM earnings before interest & taxes?
The current TTM EBIT of IBRX is -$286.38M
What is the all time high TTM EBIT for ImmunityBio?
ImmunityBio all-time high TTM earnings before interest & taxes is -$35.52M
What is ImmunityBio TTM EBIT year-on-year change?
Over the past year, IBRX TTM earnings before interest & taxes has changed by +$226.22M (+44.13%)